Next Generation Performancing Enhancing Drugs for Bodybuilders
Posted on 01:12 August 21st, 2008 by Millard Baker
Wired Magazine identifies promising medical and pharmaceutical candidates that may represent the next generation of performance enhancement for Olympic athletes. As with any performance enhancing drug, bodybuilders are always the first guinea pigs to experiment with these drugs in the real world. After they receive the seal of approval from the bodybuilding community, the new drugs are ready for athletes in other professional sports where procedures are refined to avoid detection by anti-doping agencies. Here is a list of Wired’s top ten list they feel will represent the future of doping that almost make anabolic steroids obsolete (”Cheats of Strength: 10 Next-Gen Olympic Doping Methods,” August 15).
- myostatin-inhibitor gene;
- hypoxia-inducible factor (HIF) stabilizers;
- vascular endothelial growth factor (VEGF);
- beta-endorphin gene;
- insulin-like growth factor (IGF-1);
- selective androgen receptor modulators (SARMs);
- synthetic blood substitutes e.g. Oxycyte;
- EPO-stimulating agents;
- muscle-fiber gene GW1516;
- mustard oil to increase EPO
Tags: doping, EPO, IGF-1, myostatin, SARMs
Add New Comment
Viewing 1 Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks
(Trackback URL)
August 22, 2008 at 4:59 pm
[...] designer steroids could prove a more serious challenge to anti-doping agencies than other emerging doping methods such as synthetic ...
September 5, 2008 at 5:37 pm
[...] on the losing end of an ongoing cat-and-mouse game. Anti-doping agencies are faced with several emerging doping methods such ...